EMMAC Life Sciences Group Companies
EMMAC Life Sciences Group oversees the entire supply chain
EMMAC Life Sciences Group comprises of European companies who are experts in their field, ensuring high quality control and oversight of the entire production and supply process.
By owning the full supply chain, EMMAC Life Sciences Group provides reassurance of consistent quality and supply – all grown and produced in Europe, under GacP and EU-GMP standards.
Pre-clinical and clinical research
EMMAC believes that the growth of the medical cannabis sector has to be underpinned by the most robust science. Together, EMMAC and Imperial College London are studying cannabis-derived medicinal products at both the pre-clinical and clinical level, with the aim to provide public health benefits on an international level.
World-class cultivation at Terra Verde
The first company to receive a licence to cultivate medical cannabis in Portugal, Terra Verde is a pioneer in plant-based research, genetics and production.
The result is the cultivation of consistent, natural and high-quality medicinal cannabis.
Research, Development and Manufacture at Medalchemy
Production sits with Medalchemy, a technology-based manufacturing company with over a decade of experience in research, development and manufacture of active pharmaceutical ingredients.
Rokshaw: a leading UK specials manufacturer
Rokshaw ensures patients across the UK receive the highest quality specials medicines, having already produced more than 6,000 formulations for over 2,000 hospitals and pharmacies across the UK. Rokshaw can also provide bespoke medicines for private prescriptions through CBPM Access, a registered online pharmacy.
CBPM Access: The UK’s first distance medical cannabis pharmacy
CBPM Access is the UK’s first operational distance pharmacy dedicated to fulfilling medical cannabis prescriptions, a division of its wholly owned subsidiary, Rokshaw.
Fill in the form below to receive the latest news and developments in medical cannabis from EMMAC